APA (7th ed.) Citation

Tiede, A., Abdul-Karim, F., Carcao, M., Persson, P., Clausen, W. H. O., Kearney, S., . . . Young, G. (2017). Pharmacokinetics of a novel extended half-life glyco PEGylated factor IX, nonacog beta pegol (N9- GP) in previously treated patients with haemophilia B: Results from two phase 3 clinical trials. Haemophilia, 23(4), 547. https://doi.org/10.1111/hae.13191

Chicago Style (17th ed.) Citation

Tiede, A., et al. "Pharmacokinetics of a Novel Extended Half-life Glyco PEGylated Factor IX, Nonacog Beta Pegol (N9- GP) in Previously Treated Patients with Haemophilia B: Results from Two Phase 3 Clinical Trials." Haemophilia 23, no. 4 (2017): 547. https://doi.org/10.1111/hae.13191.

MLA (9th ed.) Citation

Tiede, A., et al. "Pharmacokinetics of a Novel Extended Half-life Glyco PEGylated Factor IX, Nonacog Beta Pegol (N9- GP) in Previously Treated Patients with Haemophilia B: Results from Two Phase 3 Clinical Trials." Haemophilia, vol. 23, no. 4, 2017, p. 547, https://doi.org/10.1111/hae.13191.